Latest Boardroom Shifts News

Alicanto Minerals has appointed seasoned resources executive Jeffrey Sansom as CEO, signaling a strategic push to advance its Falun Copper-Gold Project and pursue new acquisitions. The leadership change aligns with the company’s ambitions to enhance shareholder value through disciplined growth.

Elixir Energy has raised approximately AUD 16.6 million through a two-tranche placement led by Omega Oil & Gas, aiming to fast-track its Taroom Trough gas projects and advance toward commercial production.

Aura Energy’s 2025 AGM highlights strong uranium market fundamentals and strategic progress on its Tiris Project, despite some engineering delays. The company also strengthens its board and deepens ties in Mauritania as it prepares for production.

Global Masters Fund Limited (GFL) reported a robust 19.8% total return for FY2025, surpassing the MSCI World Index, while unveiling strategic moves to diversify beyond Berkshire Hathaway into private growth and regional quality funds.

Metcash Limited has responded to an ASX query regarding the late filing of a director’s interest notice, attributing the delay to an administrative oversight and outlining plans to enhance compliance processes.

Aguia Resources has appointed Tim Hosking as its new CEO, signaling a strategic push towards phosphate production in Brazil set for early 2026, while addressing operational challenges at its Colombian gold project.

Solvar Limited has sold its New Zealand arrears loan book for NZ$8 million, accelerating its exit from the NZ market and announcing a special fully franked dividend for shareholders.

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.

Fleetwood Limited has announced the immediate departure of CEO Bruce Nicholson, with Chair John Klepec stepping in as interim CEO while a search for a permanent replacement begins.

Web Travel Group Limited reports robust half-year results for FY26, with its B2B travel division WebBeds fueling a 20% revenue increase despite rising costs and finance pressures.

Race Oncology Limited has secured shareholder approval for a replacement Constitution at its 2025 Annual General Meeting, updating its corporate governance framework to align with current regulatory standards.

Bapcor Limited has reshaped its leadership with Lachlan Edwards appointed as Chair and Angus McKay stepping down from the Board to concentrate on turning around the business as CEO.